Cargando…

CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization

The current COVID-19 pandemic has claimed hundreds of thousands of lives and its causative agent, SARS-CoV-2, has infected millions, globally. The highly contagious nature of this respiratory virus has spurred massive global efforts to develop vaccines at record speeds. In addition to enhanced immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haun, Brien K., Lai, Chih-Yun, Williams, Caitlin A., Wong, Teri Ann S., Lieberman, Michael M., Pessaint, Laurent, Andersen, Hanne, Lehrer, Axel T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661386/ https://www.ncbi.nlm.nih.gov/pubmed/33193454 http://dx.doi.org/10.3389/fimmu.2020.599587

Ejemplares similares

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
por: Lai, Chih-Yun, et al.
Publicado: (2021)

An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT™ Is Functionally Superior to Freund's Adjuvant
por: Stevens, Natalie E., et al.
Publicado: (2013)

Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model
por: Williams, Caitlin A., et al.
Publicado: (2022)

Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
por: Rosati, Margherita, et al.
Publicado: (2021)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
por: Stewart, Erica L., et al.
Publicado: (2022)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
por: Lehrer, Axel T., et al.
Publicado: (2021)

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
por: Dowell, Alexander C., et al.
Publicado: (2021)

Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
por: Lai, Chih-Yun, et al.
Publicado: (2017)

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
por: Sengupta, Anirban, et al.
Publicado: (2022)

Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants
por: Masuda, Akitsu, et al.
Publicado: (2022)

Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Antibody-mediated immunity to SARS-CoV-2 spike
por: Errico, John M., et al.
Publicado: (2022)

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
por: Stark, Felicity C., et al.
Publicado: (2022)

SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice
por: Song, Shi‐Jian, et al.
Publicado: (2022)

Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection
por: Lin, Jhe-Jhih, et al.
Publicado: (2022)

A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates
por: Medina, Liana O., et al.
Publicado: (2018)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Spiking SARS-CoV-2 antiviral immunity in the respiratory tract
por: Silva-Sanchez, Aaron, et al.
Publicado: (2023)

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals
por: Mahajan, Swapnil, et al.
Publicado: (2021)

SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
por: Carmen, Joshua M., et al.
Publicado: (2021)

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
por: Da Silva, Candido G., et al.
Publicado: (2019)

Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
por: Shim, Byoung-Shik, et al.
Publicado: (2012)

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2020)

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)

An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
por: Vijayanand, Sharon, et al.
Publicado: (2023)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2
por: Jung, Hi Eun, et al.
Publicado: (2023)

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice
por: Wørzner, Katharina, et al.
Publicado: (2021)

Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
por: Alamri, Sawsan S., et al.
Publicado: (2021)

Synergistic Immunity and Protection in Mice by Co-Immunization with DNA Vaccines Encoding the Spike Protein and Other Structural Proteins of SARS-CoV-2
por: Chen, Jinni, et al.
Publicado: (2023)

Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
por: Shan, Dan, et al.
Publicado: (2022)

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
por: Homma, Tomoyuki, et al.
Publicado: (2022)

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
por: Moga, Esther, et al.
Publicado: (2022)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice
por: Patil, Smital, et al.
Publicado: (2023)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: To, Albert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i0hsgu5fdud6sm5u4ocudtk0o4